Management of Hyponatremia

For hyponatremia management, the approach is determined by symptom severity and volume status: severe symptomatic hyponatremia requires immediate 3% hypertonic saline with a target correction of 6 mmol/L over 6 hours (never exceeding 8 mmol/L in 24 hours), while asymptomatic or mildly symptomatic cases are managed based on whether the patient is hypovolemic (isotonic saline), euvolemic (fluid restriction), or hypervolemic (fluid restriction with treatment of underlying disease). 1

Initial Assessment and Classification

Confirm True Hyponatremia

Measure serum osmolality to exclude pseudohyponatremia from hyperglycemia (add 1.6 mEq/L to measured sodium for each 100 mg/dL glucose above 100 mg/dL) or hyperlipidemia 1, 2
Hyponatremia is defined as serum sodium <135 mEq/L, with severity classified as mild (130-135 mEq/L), moderate (120-129 mEq/L), and severe (<120 mEq/L) 1, 2
Even mild hyponatremia (130-135 mEq/L) is not benign—it increases fall risk (21% vs 5% in normonatremic patients), fracture risk, cognitive impairment, and carries a 60-fold increased mortality risk when sodium drops below 130 mEq/L 3, 4

Determine Symptom Severity

Severe symptoms (medical emergency): confusion, seizures, coma, altered consciousness, or respiratory distress—these require immediate hypertonic saline regardless of sodium level 3, 1
Moderate symptoms: nausea, vomiting, headache, lethargy, muscle cramps, gait instability—these require careful correction with close monitoring 3, 2
Mild/asymptomatic: no specific symptoms but still associated with cognitive deficits and increased mortality 3, 4

Assess Volume Status

Hypovolemic signs: orthostatic hypotension, tachycardia, dry mucous membranes, decreased skin turgor, flat neck veins 1, 5
Euvolemic: no edema, normal blood pressure, moist mucous membranes, normal jugular venous pressure 1, 5
Hypervolemic signs: peripheral edema, ascites, jugular venous distention, pulmonary congestion 1, 5
Physical examination alone has poor accuracy (sensitivity 41%, specificity 80%), so supplement with laboratory findings 1

Essential Laboratory Workup

Serum osmolality (normal 275-290 mOsm/kg) to confirm hypotonic hyponatremia 1, 5
Urine osmolality: <100 mOsm/kg suggests appropriate ADH suppression; >100 mOsm/kg indicates impaired water excretion 1, 5
Urine sodium: <30 mmol/L suggests hypovolemia or low effective circulating volume; >20-40 mmol/L with high urine osmolality suggests SIADH 1, 5
Serum uric acid <4 mg/dL has 73-100% positive predictive value for SIADH 1
TSH and morning cortisol to exclude hypothyroidism and adrenal insufficiency 1, 6

Management Based on Symptom Severity

Severe Symptomatic Hyponatremia (Emergency)

This is a medical emergency requiring immediate intervention—do not delay treatment while pursuing diagnostic workup. 1, 2

Administer 3% hypertonic saline as 100 mL bolus over 10 minutes, which can be repeated up to three times at 10-minute intervals 1, 7
Target correction of 6 mmol/L over the first 6 hours or until severe symptoms resolve 1, 7
Absolute maximum correction: 8 mmol/L in any 24-hour period to prevent osmotic demyelination syndrome 1, 7, 8
Check serum sodium every 2 hours during initial correction phase 1
Admit to ICU for continuous monitoring 1

Critical safety point: A 4-6 mmol/L increase is adequate to reverse life-threatening symptoms—do not aim for normalization 7

Asymptomatic or Mildly Symptomatic Hyponatremia

Management depends on volume status and underlying cause 1, 2:

Management Based on Volume Status

Hypovolemic Hyponatremia

Caused by true sodium and volume depletion from gastrointestinal losses, diuretics, or renal salt wasting. 1, 5

Administer isotonic saline (0.9% NaCl) for volume repletion at initial rate of 15-20 mL/kg/h, then 4-14 mL/kg/h based on response 1
Discontinue diuretics immediately if sodium <125 mmol/L 1
Urine sodium <30 mmol/L predicts good response to saline (positive predictive value 71-100%) 1
Maximum correction rate: 8 mmol/L in 24 hours 1, 8
Monitor serum sodium every 4-6 hours during correction 1

Special consideration: In cirrhotic patients with hypovolemic hyponatremia, use more cautious correction (4-6 mmol/L per day maximum) and consider albumin infusion alongside isotonic saline 1

Euvolemic Hyponatremia (SIADH)

SIADH is the most common cause of euvolemic hyponatremia, characterized by inappropriate ADH activity despite low plasma osmolality. 1, 5

Diagnostic Criteria for SIADH:

Hypotonic hyponatremia (serum Na <135 mEq/L, osmolality <275 mOsm/kg) 1
Inappropriately concentrated urine (urine osmolality >100 mOsm/kg, typically >300 mOsm/kg) 1
Urine sodium >20-40 mEq/L 1
Clinical euvolemia (no edema, orthostatic hypotension, or volume depletion) 1
Normal thyroid, adrenal, and renal function 1

Treatment Algorithm for SIADH:

First-line: Fluid restriction to 1 L/day (or <800 mL/day for refractory cases) 1, 4, 6
Second-line (if fluid restriction fails after 48-72 hours): Add oral sodium chloride 100 mEq three times daily 1
Third-line options: 4, 6, 9
- Urea (30-60 g/day): Very effective and safe, though poor palatability limits use 4, 9
- Vaptans (tolvaptan 15 mg daily, titrate to 30-60 mg): Effective but risk overly rapid correction and increased thirst 4, 6
- Loop diuretics, demeclocycline, or lithium (less commonly used due to side effects) 1, 6

Common pitfall: Almost half of SIADH patients do not respond to fluid restriction alone—be prepared to escalate therapy 9

Common causes to address: Medications (SSRIs, carbamazepine, NSAIDs, opioids, chemotherapy), malignancy (especially small cell lung cancer), CNS disorders, pulmonary disease 1, 5

Hypervolemic Hyponatremia

Occurs in heart failure, cirrhosis, or nephrotic syndrome due to reduced effective circulating volume despite total body fluid overload. 1, 2

Treatment Approach:

Fluid restriction to 1-1.5 L/day for sodium <125 mmol/L 1, 2
Treat the underlying disease aggressively (optimize heart failure therapy with ACE inhibitors, beta-blockers, aldosterone antagonists; manage cirrhosis with diuretics and albumin) 1
Discontinue diuretics temporarily if sodium <125 mmol/L 1
In cirrhosis: Consider albumin infusion (8 g per liter of ascites removed) alongside fluid restriction 1
Avoid hypertonic saline unless life-threatening symptoms are present, as it worsens edema and ascites 1

Important principle: In cirrhosis, it is sodium restriction (not fluid restriction) that results in weight loss, as fluid passively follows sodium 1

Vaptans in Hypervolemic Hyponatremia:

Consider tolvaptan (15 mg daily) for persistent severe hyponatremia despite fluid restriction and optimization of guideline-directed therapy 1, 4
Use with extreme caution in cirrhosis due to higher risk of gastrointestinal bleeding (10% vs 2% placebo) and hepatotoxicity 1
Limit use to ≤30 days and monitor liver function monthly 1

Critical Correction Rate Guidelines

Standard-Risk Patients

Target correction: 4-8 mmol/L per day 1, 8
Absolute maximum: 8 mmol/L in 24 hours, 12-14 mmol/L in 48 hours, 14-16 mmol/L in 72 hours 7, 8
Check serum sodium every 4-6 hours during active correction 1

High-Risk Patients (Cirrhosis, Alcoholism, Malnutrition, Prior Encephalopathy)

Target correction: 4-6 mmol/L per day 1, 8
Absolute maximum: 8 mmol/L in 24 hours 1, 8
These patients have 0.5-1.5% risk of osmotic demyelination syndrome even with careful correction 1

Recent evidence challenge: A 2026 retrospective cohort study of 13,988 patients found that faster correction rates (>12 mmol/L in 24 hours) were associated with lower 90-day mortality and delayed neurologic events compared to slow correction (<8 mmol/L), suggesting current guidelines may be overly conservative 8. However, until prospective trials confirm these findings, adhere to the 8 mmol/L/24-hour limit to avoid osmotic demyelination syndrome 1, 7.

Management of Overcorrection

If sodium rises >8 mmol/L in 24 hours, this is a medical emergency requiring immediate intervention. 1, 7

Immediately discontinue hypertonic saline or other sodium-containing fluids 1
Administer D5W (5% dextrose in water) or hypotonic fluids to lower sodium 1, 7
Give desmopressin (2-4 mcg IV/SC) to induce water retention and reverse rapid correction 1, 7
Goal: Bring total 24-hour correction back to ≤8 mmol/L from baseline 1
Monitor for signs of osmotic demyelination syndrome (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis) typically 2-7 days after overcorrection 1

Special Populations and Scenarios

Neurosurgical Patients (Cerebral Salt Wasting vs SIADH)

In patients with acute brain injury, distinguishing cerebral salt wasting (CSW) from SIADH is critical because they require opposite treatments. 1

Cerebral Salt Wasting:

Clinical features: True hypovolemia with orthostatic hypotension, tachycardia, dry mucous membranes, CVP <6 cm H₂O 1
Lab findings: Urine sodium >20 mmol/L despite volume depletion 1
Treatment: Aggressive volume and sodium replacement with isotonic or hypertonic saline (50-100 mL/kg/day); fludrocortisone 0.1-0.2 mg daily for severe cases 1
Never use fluid restriction in CSW—it worsens outcomes and increases risk of cerebral ischemia 1

Subarachnoid Hemorrhage:

Fluid restriction is contraindicated in SAH patients at risk of vasospasm 1
Consider fludrocortisone or hydrocortisone to prevent natriuresis and reduce vasospasm risk 1

Cirrhotic Patients

Hyponatremia in cirrhosis is mostly dilutional and hypervolemic, occurring in ~60% of patients with ascites 1
Sodium ≤130 mmol/L increases risk of spontaneous bacterial peritonitis (OR 3.40), hepatorenal syndrome (OR 3.45), and hepatic encephalopathy (OR 2.36) 1
Fluid restriction to 1-1.5 L/day for sodium <125 mmol/L 1
Albumin infusion alongside fluid restriction may improve outcomes 1
Avoid hypertonic saline unless life-threatening symptoms, as it worsens ascites 1
Correction rate: 4-6 mmol/L per day maximum due to exceptionally high risk of osmotic demyelination 1

Heart Failure Patients

Continue diuretics even with mild hyponatremia (sodium 126-135 mmol/L) if volume overload persists, as stopping diuretics worsens outcomes 1
Optimize guideline-directed medical therapy (ACE inhibitors, beta-blockers, aldosterone antagonists) before adding specific hyponatremia treatments 1
Fluid restriction to 1-1.5 L/day for sodium <125 mmol/L 1
Consider vaptans for persistent severe hyponatremia despite fluid restriction and optimized heart failure therapy 1, 4

Common Pitfalls to Avoid

Overly rapid correction (>8 mmol/L in 24 hours) leading to osmotic demyelination syndrome 1, 7
Inadequate monitoring during active correction—check sodium every 2-4 hours initially 1
Using fluid restriction in cerebral salt wasting—this worsens outcomes and can be fatal 1
Failing to recognize and treat the underlying cause (medications, SIADH, heart failure, cirrhosis) 1
Using hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms—this worsens edema 1
Ignoring mild hyponatremia (130-135 mmol/L) as clinically insignificant—it increases fall risk, fractures, and mortality 3, 4
Stopping diuretics prematurely in heart failure due to mild hyponatremia when volume overload persists 1
Relying on physical examination alone for volume assessment—it has poor accuracy (sensitivity 41%, specificity 80%) 1

Monitoring Protocol

During Active Correction:

Severe symptoms: Check serum sodium every 2 hours 1
Moderate symptoms: Check serum sodium every 4 hours 1
Mild/asymptomatic: Check serum sodium every 4-6 hours initially, then daily 1
Monitor urine output, volume status, and neurologic status continuously 1
Watch for signs of overcorrection or osmotic demyelination syndrome 1

After Stabilization:

Continue monitoring sodium daily until stable 1
Address underlying cause (discontinue offending medications, treat SIADH, optimize heart failure or cirrhosis management) 1, 2
Educate patients on fluid restriction compliance if applicable 1

What is the appropriate management of hyponatremia?

Help us tailor your experience